PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
The peptide vaccine clinical trials encountered limited success because of difficulties associated with stability and delivery, resulting in inefficient antigen presentation and low response rates in patients with cancer. The purpose of this study was to develop a novel delivery approach for tumor antigenic peptides in order to elicit enhanced immu...
Alternative Titles
Full title
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_998d57b3b3f64509b9fba1d174bf561b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_998d57b3b3f64509b9fba1d174bf561b
Other Identifiers
ISSN
1178-2013,1176-9114
E-ISSN
1178-2013
DOI
10.2147/IJN.S29506
